Granules India, incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 6691.27 Crore) operating in Pharmaceuticals sector.
Granules India key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 1198.88 Crore, up 4.52 % from last quarter Total Income of Rs 1147.07 Crore and up 15.95 % from last year same quarter Total Income of Rs 1033.93 Crore. Company has reported net profit after tax of Rs 119.60 Crore in latest quarter.
The company’s top management includes Mr.Krishna Prasad Chigurupati, Dr.Saumen Chakraborty, Mr.Robert George Cunard, Mr.Arun Sawhney, Mr.Arun Rao Akinepally, Mr.K B Sankar Rao, Mr.Harsha Chigurupati, Mrs.Uma Devi Chigurupati, Dr.K V S Ram Rao, Mrs.Sucharita Rao Palepu. Company has B S R & Associates LLP as its auditors. As on 31-03-2023, the company has a total of 24 Crore shares outstanding.
Promoter/FII Holdings
Promoters held 42.02 per cent stake in the company as of 31-Mar-2023, while FIIs owned 23.9 per cent, DIIs 5.03 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price